These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31432319)

  • 1. Early prediction of donepezil cognitive response in Alzheimer's disease by brain perfusion single photon emission tomography.
    Tepmongkol S; Hemrungrojn S; Dupont P; Tunvirachaisakul C; Aniwattanapong D; Likitjareon Y; Supasitthumrong T; Tawankanjanachot I; Siritranon N; Chuchuen P; Natsawang B; Tangwongchai S
    Brain Imaging Behav; 2019 Dec; 13(6):1665-1673. PubMed ID: 31432319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
    Shirayama Y; Takahashi M; Oda Y; Yoshino K; Sato K; Okubo T; Iyo M
    Brain Imaging Behav; 2019 Feb; 13(1):75-86. PubMed ID: 29247294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease.
    Rodriguez G; Vitali P; Canfora M; Calvini P; Girtler N; De Leo C; Piccardo A; Nobili F
    Clin Neurophysiol; 2004 Jan; 115(1):39-49. PubMed ID: 14706467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of therapeutic response to donepezil by positron emission tomography.
    Shimada A; Hashimoto H; Kawabe J; Higashiyama S; Kai T; Kataoka K; Tagawa R; Kawarada Y; Nakanishi A; Inoue K; Shiomi S; Kiriike N
    Osaka City Med J; 2011 Jun; 57(1):11-9. PubMed ID: 22106763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.
    Nobili F; Vitali P; Canfora M; Girtler N; De Leo C; Mariani G; Pupi A; Rodriguez G
    Clin Neurophysiol; 2002 Aug; 113(8):1241-8. PubMed ID: 12140003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease.
    Yoshida T; Ha-Kawa S; Yoshimura M; Nobuhara K; Kinoshita T; Sawada S
    Ann Nucl Med; 2007 Jul; 21(5):257-65. PubMed ID: 17634843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a high dosage of donepezil for Alzheimer's disease as examined by single-photon emission computed tomography imaging.
    Kanaya K; Abe S; Sakai M; Fujii H; Koizumi K; Iwamoto T
    Psychogeriatrics; 2012 Sep; 12(3):172-8. PubMed ID: 22994615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease.
    Oka M; Nakaaki S; Negi A; Miyata J; Nakagawa A; Hirono N; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):121-34. PubMed ID: 26114924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual form of Alzheimer's disease and its response to anticholinesterase therapy.
    Warren S; Hier DB; Pavel D
    J Neuroimaging; 1998 Oct; 8(4):249-52. PubMed ID: 9780861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of donepezil on the amplitude of low-frequency fluctuations in the brain of patients with Alzheimer's disease: evidence from resting-state functional magnetic resonance imaging.
    Yang H; Zhang J; Cheng J
    Neuroreport; 2021 Aug; 32(11):907-912. PubMed ID: 34029287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease.
    Ceravolo R; Volterrani D; Tognoni G; Dell'Agnello G; Manca G; Kiferle L; Rossi C; Logi C; Strauss HW; Mariani G; Murri L
    Clin Neuropharmacol; 2004; 27(4):166-70. PubMed ID: 15319702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses to donepezil in Alzheimer's disease and Parkinson's disease.
    Mori S
    Ann N Y Acad Sci; 2002 Nov; 977():493-500. PubMed ID: 12480791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase inhibitors are compatible with psychosocial intervention for Alzheimer disease patients suggested by neuroimaging findings.
    Meguro K
    Psychiatry Res Neuroimaging; 2017 Jan; 259():29-33. PubMed ID: 27940150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic enhancement increases regional cerebral blood flow to the posterior cingulate cortex in mild Alzheimer's disease.
    Iizuka T; Kameyama M
    Geriatr Gerontol Int; 2017 Jun; 17(6):951-958. PubMed ID: 27215917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy.
    Higashiyama S; Kawabe J; Hashimoto H; Akiyama H; Kawamura E; Torii K; Inoue K; Kiriike N; Shiomi S; Inoue Y
    Osaka City Med J; 2006 Dec; 52(2):55-62. PubMed ID: 17330392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT-identified neuroanatomical predictor of the cognitive effects of donepezil treatment in patients with Alzheimer's disease.
    Hongo J; Nakaaki S; Shinagawa Y; Murata Y; Sato J; Tatsumi H; Tohyama J; Soma T; Iidaka T; Fukui T; Mimura M; Furukawa TA
    Dement Geriatr Cogn Disord; 2008; 26(6):556-66. PubMed ID: 19066429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of response to donepezil in Alzheimer's disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion.
    Kanetaka H; Hanyu H; Hirao K; Shimizu S; Sato T; Akai T; Iwamoto T; Koizumi K
    Nucl Med Commun; 2008 Jun; 29(6):568-73. PubMed ID: 18458605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer's disease.
    Shimizu S; Hanyu H; Iwamoto T; Koizumi K; Abe K
    J Neuroimaging; 2006 Jan; 16(1):16-23. PubMed ID: 16483272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.